Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1234 (LINC01234)

Target
LINC01234
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 1234 (LINC01234) is a long non-coding RNA located on chromosome 12q24.13, annotated as non-protein coding and known by several aliases including MBOP, LCAL84, MEK1-binding oncopeptide, and onco-lncRNA-32. LINC01234 is frequently upregulated in multiple types of human cancers such as breast, colon, lung, gastric, liver cancer, and multiple myeloma. It promotes tumor cell proliferation, cycle progression, migration, and suppresses apoptosis, primarily by acting as a molecular sponge for specific tumor-suppressive microRNAs (such as miR-429, miR-642a-5p, and miR-124-3p), resulting in de-repression of oncogenic mRNA targets (such as SYNJ1, SHMT2, and possibly GRB2). LINC01234 has been identified as a potential prognostic biomarker and a putative therapeutic target in several cancers because of its oncogenic roles. However, there are currently no known approved drugs that selectively target LINC01234 directly, and available studies largely focus on preclinical and experimental RNA interference or antisense strategies.

Other names
MBOPLCAL84MEK1-binding oncopeptideonco-lncRNA-32ONCO-LNC01234
02

Mechanism of action

Functions as a competing endogenous RNA (ceRNA), sponging tumor-suppressive microRNAs (such as miR-429, miR-642a-5p, miR-124-3p), thereby derepressing oncogenes and promoting cell proliferation and cancer progression

03

Biological functions

Regulation of cell proliferationRegulation of cell cycle progressionInhibition of apoptosisCompeting endogenous RNA (ceRNA)/miRNA sponge
04

Disease associations

CancerBreast cancerColon cancerLung cancerGastric cancerLiver cancerMultiple myeloma
05

Safety considerations

Potential challenge of specificity in targeting lncRNAsPossible off-target and cell-type specific effects due to broad expression regulation and interactions with multiple cellular pathways
06

Biomarkers

Prognostic biomarker in several cancers (e.g., breast cancer signature, colon cancer prognosis, possible diagnostic role in others)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1234 (LINC01234).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1234 (LINC01234).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call